OptiLight is a light-based treatment that uses precise, intense broad-spectrum light to address dry eye
disease due to meibomian gland dysfunction (MGD). MGD is the most common cause of dry eye disease,
accounting for about 86% of cases. The treatment addresses inflammation, which is one of the key
underlying factors in MGD. OptiLight was specifically developed to reach the delicate contours of the
treated area safely, effectively and gently using the OPT™ technology.
Lumenis’ patented technology OPT™ (Optimal Pulse Technology) transforms the use of light and allows
targeted, uniform, precise, and controlled treatment. Specifically designed for the delicate area below the
eye, OPT™ safely and effectively breaks the vicious cycle of inflammation associated with dry eye
OptiLight is a multi-factorial treatment for a multi-factorial disease. It addresses the disease by reducing
major sources of inflammation leading to dry eye disease such as abnormal blood vessels, Demodex
mites, and pro-inflammatory agents. OptiLight restores the function of meibomian glands and delays
evaporation of the tear film.
Treatment protocol typically consists of 4 sessions, at 2 to 4 weeks apart:
Patients typically report improvement after 2 to 3 treatments. For optimal results, 4 sessions are advised.
To ensure long-term results, a maintenance session is recommended every 6-12 months.
You may experience some redness immediately following treatment. This will usually disappear within a
few hours. You can return to your daily activities and apply makeup straight away in most cases. You will
be advised to stay out of direct sunlight for a few days and to apply sunscreen.
Copyright © 2024 Nikoumanesh Eye Care - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your anonymized data will be used with other aggregated data.